AbbVie's Stock Is a Bargain After Falling 8% Last Week
AbbVie's stock got walloped last week on fears the FDA could open the door to a knock-off version of Humira sooner than expected.
Monday, July 23, 2018
AbbVie's Stock Is a Bargain After Falling 8% Last Week
AbbVie's Stock Is a Bargain After Falling 8% Last Week
AbbVie's stock got walloped last week on fears the FDA could open the door to a knock-off version of Humira sooner than expected.
Related Posts:
A.G. Sulzberger, 37, to Take Over as New York Times Publisher- Labor Board Reverses Ruling That Helped Workers Fight Chains
- Lamborghini’s Urus Is the Luxury S.U.V. Party’s Most Flamboyant Guest
- Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping
- Ford Chooses a Detroit Base to Take On Silicon Valley
0 comments:
Post a Comment